Giorgio V Scagliotti Selected Research

Vitamin B 12 (Cyanocobalamin)

1/2007	Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer.
4/2003	Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio V Scagliotti Research Topics

Disease

64	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2003
57	Neoplasms (Cancer) 01/2024 - 05/2003
27	Lung Neoplasms (Lung Cancer) 11/2023 - 07/2003
16	Adenocarcinoma 04/2023 - 05/2002
14	Malignant Mesothelioma 03/2023 - 04/2003
13	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 03/2016
12	Carcinoma (Carcinomatosis) 04/2018 - 05/2002
11	Neoplasm Metastasis (Metastasis) 04/2022 - 12/2004
9	Disease Progression 05/2021 - 07/2003
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 05/2002
6	Mesothelioma 12/2023 - 02/2006
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2023 - 06/2008
5	Large Cell Carcinoma 05/2012 - 05/2002
4	Neutropenia 01/2019 - 01/2012
3	Adenocarcinoma of Lung 10/2021 - 06/2006
3	Fatigue 04/2018 - 06/2012
3	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 11/2006 - 10/2005
2	Anemia 10/2022 - 04/2018
2	Pain (Aches) 04/2022 - 03/2016
2	Pleurisy (Pleuritis) 01/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 07/2020 - 08/2003
2	Hypoxia (Hypoxemia) 05/2018 - 08/2014
2	Adrenocortical Carcinoma 06/2017 - 08/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2017 - 01/2017
2	Lymphatic Metastasis 01/2015 - 09/2010
2	Osteosarcoma (Osteogenic Sarcoma) 11/2013 - 09/2012
2	Exanthema (Rash) 06/2012 - 10/2011

Drug/Important Bio-Agent (IBA)

23	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2003
21	Pemetrexed (MTA)FDA Link 01/2019 - 04/2003
11	Proteins (Proteins, Gene)FDA Link 03/2016 - 05/2002
11	Thymidylate SynthaseIBA 09/2015 - 02/2006
10	Biomarkers (Surrogate Marker)IBA 05/2023 - 07/2008
10	PlatinumIBA 05/2021 - 07/2003
10	Gemcitabine FDA Link 01/2013 - 07/2003
8	enzalutamideIBA 12/2021 - 03/2016
8	Carboplatin (JM8)FDA LinkGeneric 08/2014 - 01/2005
7	ErbB Receptors (EGF Receptor)IBA 05/2021 - 06/2004
6	abirateroneIBA 12/2021 - 03/2016
6	Tyrosine Kinase InhibitorsIBA 05/2021 - 11/2006
6	Hormones (Hormone)IBA 07/2020 - 11/2012
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 11/2006
6	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2003
6	Paclitaxel (Taxol)FDA LinkGeneric 08/2014 - 12/2004
5	Messenger RNA (mRNA)IBA 03/2013 - 10/2006
4	LigandsIBA 04/2022 - 09/2007
4	Abiraterone AcetateIBA 01/2021 - 08/2017
4	AndrogensIBA 01/2021 - 08/2017
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019 - 08/2012
4	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 11/2009
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 01/2021
3	AntigensIBA 11/2023 - 03/2016
3	AsbestosIBA 01/2022 - 07/2008
3	ARQ 197IBA 01/2019 - 09/2012
3	MucinsIBA 01/2019 - 09/2007
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 01/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2006
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2013 - 12/2004
3	Gefitinib (Iressa)FDA Link 10/2011 - 11/2006
3	Folic Acid AntagonistsIBA 03/2009 - 02/2006
3	Epidermal Growth Factor (EGF)IBA 09/2007 - 08/2003
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 05/2023 - 09/2015
2	Radium-223IBA 12/2022 - 03/2016
2	talazoparibIBA 10/2022 - 01/2021
2	Diphosphonates (Bisphosphonates)IBA 04/2022 - 12/2005
2	Zoledronic Acid (Zometa)FDA Link 04/2022 - 03/2016
2	Denosumab FDA Link 04/2022 - 03/2016
2	Circulating Tumor DNAIBA 10/2021 - 01/2018
2	1-methyl-1-piperidinomethane sulfonateIBA 01/2021 - 01/2018
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 08/2012
2	nintedanibIBA 01/2019 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2017
2	Leucovorin (Folinic Acid)FDA Link 05/2018 - 01/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 02/2008
2	Bevacizumab (Avastin)FDA Link 01/2017 - 11/2009
2	Dasatinib (BMS 354825)FDA Link 03/2016 - 11/2009
2	Formaldehyde (Formol)FDA Link 03/2015 - 10/2006
2	ParaffinIBA 03/2015 - 10/2006
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2015 - 03/2013
2	MicroRNAs (MicroRNA)IBA 01/2015 - 08/2014
2	motesanib diphosphateIBA 08/2014 - 08/2012
2	Guanidine (Guanidine Nitrate)FDA Link 11/2013 - 09/2012
2	NucleotidesIBA 03/2013 - 06/2004
2	Sunitinib (Sutent)FDA Link 06/2012 - 02/2008
2	src-Family KinasesIBA 04/2012 - 11/2009
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2012 - 11/2009
2	Cytotoxins (Cytolysins)IBA 05/2009 - 01/2003
2	Etoposide (VP 16)FDA LinkGeneric 06/2008 - 12/2004
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2007 - 04/2003
2	AntimetabolitesIBA 10/2006 - 02/2006

Therapy/Procedure

33	Therapeutics 01/2023 - 04/2003
32	Drug Therapy (Chemotherapy) 11/2023 - 07/2003
13	Castration 12/2022 - 03/2016
11	Immunotherapy 01/2024 - 01/2016
4	Radiotherapy 01/2017 - 10/2003
3	Precision Medicine 10/2021 - 01/2017
3	Neoadjuvant Therapy 12/2018 - 08/2003
3	Adjuvant Chemotherapy 07/2005 - 10/2003
2	Molecular Targeted Therapy 04/2023 - 01/2017
2	Duration of Therapy 10/2022 - 01/2020